The Adverse Impact of Glaucoma on Psychological Function and Daily Physical Activity
Table 3
Differences in accelerometry data between patients with early-, moderate-, and advanced-stage glaucoma and healthy control subjects.
Accelerometry data
Diagnosis
Mean (SD)
Mean difference (SD)
valuea
valueb
valuec
Daily step count
Normal (ref)
12703.77 (2922.34)
—
—
—
—
Early-stage glaucoma
13341.77 (2026.99)
638.00 (989.94)
0.521
—
—
Moderate-stage glaucoma
12000.38 (2940.45)
–703.39 (1179.50)
0.553
0.352
-
Advanced-stage glaucoma
11209.22 (2422.61)
–1494.55 (702.83)
0.037
0.051
0.530
MVPA (%)
Normal (ref)
14.24 (5.32)
—
—
—
—
Early-stage glaucoma
11.87 (7.35)
–2.36 (2.38)
0.323
—
—
Moderate-stage glaucoma
14.92 (13.39)
0.67 (2.65)
0.799
0.359
—
Advanced-stage glaucoma
13.51 (5.94)
–0.73 (1.50)
0.628
0.509
0.607
Sleep quality (%)
Normal (ref)
90.51 (5.14)
—
—
—
—
Early-stage glaucoma
91.59 (3.07)
1.07 (1.64)
0.515
—
—
Moderate-stage glaucoma
93.98 (2.65)
3.47 (1.82)
0.061
0.293
—
Advanced-stage glaucoma
90.26 (4.07)
–0.25 (1.03)
0.807
0.306
0.050
Metabolic rate (%)
Normal (ref)
1.43 (0.24)
—
—
—
—
Early-stage glaucoma
1.43 (0.16)
0.00 (0.07)
0.965
—
—
Moderate-stage glaucoma
1.32 (0.11)
–0.11 (0.07)
0.162
0.247
—
Advanced-stage glaucoma
1.40 (0.11)
–0.03 (0.04)
0.454
0.619
0.342
The data are presented as mean (SD). p valuea: early-, moderate-, and advanced-stage glaucoma vs. normal; p valueb: moderate- and advanced-stage glaucoma vs. early-stage glaucoma; p valuec: advanced-stage glaucoma vs moderate-stage glaucoma.
